Moussa Coulibaly, Ansoumane Hawa Keita, Benzalim Meriam, Soumaya Alj
Radiology, Centre Hospitalier Universitaire (CHU) Mohammed VI, Marrakech, MAR.
Cureus. 2022 Sep 1;14(9):e28666. doi: 10.7759/cureus.28666. eCollection 2022 Sep.
Ureteral hematoma is a rare complication occurring during anticoagulant therapy, with fewer than 10 cases reported in the literature. Bleeding complications are underestimated. They affect about 10% of patients treated with long-term anti-vitamin K (AVK). The appearance of macroscopic hematuria may indicate the presence of underlying organic damage. Clinically, ureteral hematoma is manifested by lumbar or abdominal pain often associated with macroscopic hematuria. Imaging plays a major role in its diagnosis. Clinical and radiological evolution is always rapidly favorable after the correction of coagulation disorders and the immediate discontinuation of anticoagulant treatment. We report in this work the case of a patient in her 50s who presented a ureteral hematoma during her anticoagulant treatment.
输尿管血肿是抗凝治疗期间发生的一种罕见并发症,文献报道的病例不足10例。出血并发症常被低估。长期使用维生素K拮抗剂(AVK)治疗的患者中约10%会出现此类并发症。肉眼血尿的出现可能提示存在潜在的器质性损伤。临床上,输尿管血肿表现为常伴有肉眼血尿的腰腹痛。影像学检查在其诊断中起主要作用。纠正凝血障碍并立即停用抗凝治疗后,临床和影像学表现通常会迅速好转。我们在本研究中报告了一例50多岁女性患者在抗凝治疗期间出现输尿管血肿的病例。